Two recent studies indicated that KIR3DL3 might down-regulate NK cell functions through binding to HHLA2 (also called B7-H7), a B7 family molecule expressed on antigen-presenting cells and highly expressed in many human cancers [178,179]. This evidence concerns the gene HHLA2 and cancer.